Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W North

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|October 6, 1992
Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2'-deoxyadenosine-5'-triphosphateR C Cronn, K M Remington, B D Preston, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency virusesT W North, R C Cronn, K M Remington, et al.
Biochemistry|May 28, 1996
Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virusH Chen, D G McBroom, Y Q Zhu, et al.
Journal of Virology|January 1, 1991
Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidineK M Remington, B Chesebro, K Wehrly, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coliT W North, G L Hansen, Y Zhu, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1980
Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in miceW M Shannon, G Arnett, F M Schabel, et al.
The Journal of Biological Chemistry|March 25, 1990
Characterization of reverse transcriptase from feline immunodeficiency virusT W North, R C Cronn, K M Remington, et al.
Antiviral Research|April 1, 1995
Models of antiviral resistanceD W Kimberlin, E R Kern, R W Sidwell, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1996
Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidineH K Medlin, Y Q Zhu, K M Remington, et al.
The Journal of Biological Chemistry|January 5, 2000
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active siteG J Klarmann, R A Smith, R F Schinazi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|October 6, 1992
Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2'-deoxyadenosine-5'-triphosphateR C Cronn, K M Remington, B D Preston, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency virusesT W North, R C Cronn, K M Remington, et al.
Biochemistry|May 28, 1996
Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virusH Chen, D G McBroom, Y Q Zhu, et al.
Journal of Virology|January 1, 1991
Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidineK M Remington, B Chesebro, K Wehrly, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coliT W North, G L Hansen, Y Zhu, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1980
Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in miceW M Shannon, G Arnett, F M Schabel, et al.
The Journal of Biological Chemistry|March 25, 1990
Characterization of reverse transcriptase from feline immunodeficiency virusT W North, R C Cronn, K M Remington, et al.
Antiviral Research|April 1, 1995
Models of antiviral resistanceD W Kimberlin, E R Kern, R W Sidwell, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1996
Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidineH K Medlin, Y Q Zhu, K M Remington, et al.
The Journal of Biological Chemistry|January 5, 2000
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active siteG J Klarmann, R A Smith, R F Schinazi, et al.
Pageof 4